Press Releases
Advertisement
Advertisement
Please check back later for more content.
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Announces Nine More TrumpRx Participants
2
Eli Lilly Announces Topline Results From Phase III Trial Studying Oral GLP-1 Therapy Orforglipron
3
Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release
4
BioMarin Reaches $4.8 Billion Definitive Agreement to Acquire Amicus Therapeutics
5